Market Cap 724.36M
Revenue (ttm) 332.31M
Net Income (ttm) -51.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15.57%
Debt to Equity Ratio -0.34
Volume 6,122,100
Avg Vol 7,315,314
Day's Range N/A - N/A
Shares Out 239.06M
Stochastic %K 64%
Beta 0.92
Analysts Sell
Price Target $6.10

Company Profile

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovasc...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 734 887 3903
Address:
3891 Ranchero Drive, Suite 150, Ann Arbor, United States
HowDidThatGetInThere
HowDidThatGetInThere Nov. 14 at 5:26 PM
$ESPR At least it's fighting for it's life at this $3 mark, better than going back in the $2.70's pr $2.80's. Just a matter of time at this point for the pressure from the bottle to pop the cork off.
0 · Reply
nomalarkey
nomalarkey Nov. 14 at 5:23 PM
$ESPR Indeed, the chart is predicting massive growth
0 · Reply
djohnson591
djohnson591 Nov. 14 at 5:20 PM
$ESPR It was probably another "coincidence" the all the Brinks accounts stopped posting and other influencers disappeared around the same time. So.....many......."coincidences"
0 · Reply
md725
md725 Nov. 14 at 5:20 PM
$ESPR Boom … Jane Street buy 1,349,283 new shares in Q3. Integral Health buy 1,500,000 new shares in Q3.
1 · Reply
djohnson591
djohnson591 Nov. 14 at 5:18 PM
$ESPR Unfortunately, we won't know who was involved in the latest offering until Feb 15th, since they did it within days of Q4 starting and don't have to report it until 45 days after the quarter ends. Always conveniently non-transparent timing as usual, must be another "coincidence". I have some guesses on who was involved.
0 · Reply
Gary9912
Gary9912 Nov. 14 at 5:16 PM
$ESPR Cups, handles, white soldiers, ichimoku clouds, rocket fuel 📈📈📈
1 · Reply
Stock765
Stock765 Nov. 14 at 5:12 PM
$ESPR Ok, lets leave this 2 forever now.
0 · Reply
djohnson591
djohnson591 Nov. 14 at 5:06 PM
$ESPR Two Seas had 9,954,975 shares in Q2 - They stayed about the same in Q3
0 · Reply
DP000
DP000 Nov. 14 at 5:04 PM
$ESPR https://hlstherapeutics.com/English/investor-relations/investor-news/news-details/2025/HLS-Therapeutics-Announces-Q3-2025-Financial-Results/default.aspx
0 · Reply
profitsforall
profitsforall Nov. 14 at 5:03 PM
$ESPR Total trading volume so far 1.8 million shares. and as of right now the Schwab shares available to short has gone DOWN by 800K Today to Limited (1,830,118).
0 · Reply
Latest News on ESPR
Esperion Announces Pricing of Public Offering of Common Stock

Oct 7, 2025, 9:29 PM EDT - 5 weeks ago

Esperion Announces Pricing of Public Offering of Common Stock


Esperion Announces Proposed Public Offering of Common Stock

Oct 7, 2025, 4:01 PM EDT - 5 weeks ago

Esperion Announces Proposed Public Offering of Common Stock


Top 2 Health Care Stocks That May Plunge This Month

Sep 5, 2025, 10:39 AM EDT - 2 months ago

Top 2 Health Care Stocks That May Plunge This Month

NUVB


Esperion Appoints Craig Thompson to Board of Directors

Jul 1, 2025, 8:06 AM EDT - 4 months ago

Esperion Appoints Craig Thompson to Board of Directors


Esperion to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 8:00 AM EDT - 7 months ago

Esperion to Participate in The Citizens Life Sciences Conference


Esperion Appoints Robert E. Hoffman to Board of Directors

Apr 1, 2025, 8:00 AM EDT - 8 months ago

Esperion Appoints Robert E. Hoffman to Board of Directors


Esperion Announces $210 Million Convertible Debt Financing

Dec 13, 2024, 6:00 AM EST - 1 year ago

Esperion Announces $210 Million Convertible Debt Financing


Esperion Therapeutics: Strategically Positioned To Grow

Aug 16, 2024, 4:09 AM EDT - 1 year ago

Esperion Therapeutics: Strategically Positioned To Grow


HowDidThatGetInThere
HowDidThatGetInThere Nov. 14 at 5:26 PM
$ESPR At least it's fighting for it's life at this $3 mark, better than going back in the $2.70's pr $2.80's. Just a matter of time at this point for the pressure from the bottle to pop the cork off.
0 · Reply
nomalarkey
nomalarkey Nov. 14 at 5:23 PM
$ESPR Indeed, the chart is predicting massive growth
0 · Reply
djohnson591
djohnson591 Nov. 14 at 5:20 PM
$ESPR It was probably another "coincidence" the all the Brinks accounts stopped posting and other influencers disappeared around the same time. So.....many......."coincidences"
0 · Reply
md725
md725 Nov. 14 at 5:20 PM
$ESPR Boom … Jane Street buy 1,349,283 new shares in Q3. Integral Health buy 1,500,000 new shares in Q3.
1 · Reply
djohnson591
djohnson591 Nov. 14 at 5:18 PM
$ESPR Unfortunately, we won't know who was involved in the latest offering until Feb 15th, since they did it within days of Q4 starting and don't have to report it until 45 days after the quarter ends. Always conveniently non-transparent timing as usual, must be another "coincidence". I have some guesses on who was involved.
0 · Reply
Gary9912
Gary9912 Nov. 14 at 5:16 PM
$ESPR Cups, handles, white soldiers, ichimoku clouds, rocket fuel 📈📈📈
1 · Reply
Stock765
Stock765 Nov. 14 at 5:12 PM
$ESPR Ok, lets leave this 2 forever now.
0 · Reply
djohnson591
djohnson591 Nov. 14 at 5:06 PM
$ESPR Two Seas had 9,954,975 shares in Q2 - They stayed about the same in Q3
0 · Reply
DP000
DP000 Nov. 14 at 5:04 PM
$ESPR https://hlstherapeutics.com/English/investor-relations/investor-news/news-details/2025/HLS-Therapeutics-Announces-Q3-2025-Financial-Results/default.aspx
0 · Reply
profitsforall
profitsforall Nov. 14 at 5:03 PM
$ESPR Total trading volume so far 1.8 million shares. and as of right now the Schwab shares available to short has gone DOWN by 800K Today to Limited (1,830,118).
0 · Reply
MrPeter
MrPeter Nov. 14 at 5:01 PM
$ESPR was did Two Seas have last qtr ? DJ?
1 · Reply
djohnson591
djohnson591 Nov. 14 at 4:53 PM
$ESPR This is a massive low volume bull flag with divergence. It's also right at that psychological level. Not to mention the one year cup and handle. I would not be surprised to see this much higher at the end of next week.
0 · Reply
DP000
DP000 Nov. 14 at 4:52 PM
$ESPR 😎 Absolutely
0 · Reply
Gary9912
Gary9912 Nov. 14 at 4:47 PM
$ESPR Two seas has almost 10M shares
2 · Reply
Mupersak1234
Mupersak1234 Nov. 14 at 4:37 PM
$ESPR Go go go
0 · Reply
djohnson591
djohnson591 Nov. 14 at 4:35 PM
$ESPR https://www.tradingview.com/symbols/FINRA-PFE5307022/
2 · Reply
DeltaVariant
DeltaVariant Nov. 14 at 4:33 PM
$ESPR Let the party begin...
0 · Reply
AndreaRR
AndreaRR Nov. 14 at 4:30 PM
$ESPR You will be pleased to know that this week too the scripts of nexlizet and nextletol grew by 0.5%, another record for both
0 · Reply
djohnson591
djohnson591 Nov. 14 at 4:28 PM
$ESPR Judging by the chart for ESPR's remaining $55M in convertible bonds, it looks like ESPR paid them off in late September. This is where the chart stops reporting and there is no pricing data for Oct (which usually updates within 3 business days after month end). I also can't seem to find ownership data on Fintel anymore either. I wonder if the offering went to some of the bond holders, it happened just a week later? These events seem tied together..........Lot's of moving pieces going on in the background.
2 · Reply
drive_in_buffet
drive_in_buffet Nov. 14 at 4:22 PM
$ESPR Dr. Tsunao Saitoh, anyone?
0 · Reply
Petey3163
Petey3163 Nov. 14 at 4:14 PM
$ESPR at least it’s not .70 🙈
0 · Reply
PKinUK16
PKinUK16 Nov. 14 at 4:06 PM
$ESPR so the sequence of events - Jeffries meeting in London next week and then they fly to Japan after that to meet up with Otsuka and celebrate the launch. Correct? I’m messaging PR about the debt payment and the other items. I highly recommend you email them as well. Be professional :) Alina Venezia mailto:[email protected] (734) 887-3903
2 · Reply